Lori G. Cohen is Co-Chair of the firm's Global Litigation Practice, Chair of the firm's Trial Practice Group, as well as Chair of the Pharmaceutical, Medical Device & Health Care Litigation Practice. She is also Co-Chair of the Atlanta Litigation Practice. Lori has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. Lori is National Counsel for a medical device manufacturer, handling its litigation including class actions, multidistrict litigation, and trials nationally. She has served as both National Counsel and Regional Counsel for pharmaceutical and medical device companies and has expertise in mass tort, multidistrict and class action litigation. She also has vast experience in other products liability litigation and jury trials of all kinds. She has defended numerous health care providers, including physicians, hospitals and managed care entities nationwide.
Lori has obtained 57 defense verdicts at trial. During recent years, she obtained defense verdicts as a result of a two-month trial with $28 million in alleged damages involving pelvic mesh implants against a medical device manufacturer of women’s health products; a two-month trial with $30 million in alleged damages involving a laser-resistant endotracheal tube against a medical device manufacturer; a three-month trial with $78 million in alleged damages against the world's leading manufacturer of pacemakers; a four-week trial with $20 million in alleged damages involving an implantable neurostimulation device; a four-week trial with $18 million in alleged damages involving three consolidated cases against the manufacturer of a continuous local anesthesia infusion drug pump; and a three-week medical malpractice trial for a hospital involving allegations of an overdose on a patient controlled analgesia (PCA) pump.
Lori has been selected as a Law360 2016 "Trial MVP," a Law360 2015 "Trial Aces," a Law360 2012 "Top Female Trial Attorney” and has been profiled twice in The National Law Journal’s "Winning Litigators," a special report recognizing the top litigators in the U.S., most recently in 2016. Courtroom View Network recognized her team’s victory in a $28 million pelvic mesh trial as the "Top Defense Verdict of 2016." She has been recognized by The National Law Journal as one of "The 50 Most Influential Women Lawyers in America." The National Law Journal has recognized two of her defense trial victories as "Top Defense Wins" in recent years, The American Lawyer recognized Lori’s team as their 2018 "Products Liability Litigation Department of the Year," and she has been featured in The National Law Journal’s "Top 40 Under 40," which highlights the 40 most successful litigators under the age of 40 in the country. She is listed in The Best Lawyers in America, The Legal 500 United States, The Legal 500 "Leading Trial Lawyers," Chambers USA Guide, Outstanding Lawyers in America, The International Who's Who of Business Lawyers, The International Who's Who of Life Science Lawyers, The International Who's Who of Products Liability Defense Lawyers, Georgia Trend's "Legal Elite" and Georgia Super Lawyers magazine, including "Top 10 Georgia Super Lawyers" (2013-2018), "Top 100 Georgia Super Lawyers" (2005-2018) and "Top 50 Female Georgia Super Lawyers" (2005-2018), and she was shortlisted in Euromoney Legal Media Group’s 2017 Americas Women in Business Awards as one of the "Best in Life Sciences." Lori was one of a very small group of attorneys selected nationally for inclusion in the 2010-2018 editions of Chambers and Partners USA Guide's National Pharmaceutical Industry Products Liability Table.
Lori is highlighted for having a reputation for "using creative approaches to explain to lay jurors complex evidence." In addition to her vast trial experience, she has significant Daubert and scientific expertise with a number of her victories captured in published opinions. She has worked extensively on and lectured nationally regarding the use of technology in courtroom presentations of complex medical, scientific and other catastrophic injury cases.